gilead sciences hiv - Search News

News

FDA Approves Gilead’s HIV Shot. It Works 99.9% of Time.

Barron's on MSN · 19h

FDA Approves Gilead’s HIV Shot. It Works 99.9% of the Time.

The Food and Drug Administration approved a twice-yearly shot that prevented HIV infections in 99.9% of the people who received it in large clinical trials. The drug, developed by Gilead Sciences and called Yeztugo,

Fox News on MSN · 2h

FDA approves first twice-yearly injection that prevents HIV infection

The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.

USA TODAY on MSN · 19h

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

5h

US approves Gilead’s twice-yearly shot for HIV prevention

The US Food and Drug Administration on Wednesday approved Gilead Sciences’ twice-yearly injection to prevent HIV - a move the ...

1d

Should You Buy Gilead Stock At $110?

Gilead Sciences (NASDAQ:GILD) has demonstrated a strong performance this year, with its stock up 18% compared to the S&P ...

Gilead Researcher Awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award

Gilead has been a leader in HIV innovation for decades. Now, we're proud to share that one of our researchers, Moupali Das, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results